Caris Life Sciences, Inc. (CAI)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS1421521071
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Caris Life Sciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:28. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | 0.11 | — | — | Upcoming |
| 04 Nov 2026 16:00 | 0.02 | 0.05 | +148.5% | Beat |
| 05 Aug 2026 16:00 | 0.01 | — | -100.0% | — |
| 07 May 2026 16:00 | -0.02 | — | +100.0% | — |
| 26 Feb 2026 16:00 | 0.10 | 0.28 | +168.7% | Beat |
| 05 Nov 2025 16:00 | -0.14 | 0.08 | +158.8% | Beat |
| 12 Aug 2025 16:00 | -0.22 | -1.11 | -411.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 812M | +97.0% | -68.1M | -8.4% | -3.22 | -136.6% | 66.9M |
| 2024 | 412.3M | +34.7% | -281.9M | -68.4% | -1.36 | +25.0% | -253.6M |
| 2023 | 306.1M | +18.4% | -341.4M | -111.5% | -1.82 | -15.7% | -298.4M |
| 2022 | 258.5M | — | -320.8M | -124.1% | -1.57 | — | -328M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 34.95 | 35.05 | 22.58 | 22.79 | -33.61% | 47,247,586 | |
| Oct 2026 | 30.60 | 36.50 | 25.87 | 34.33 | +12.08% | 79,949,500 | |
| Sep 2026 | 25.60 | 32.89 | 23.20 | 30.63 | +20.16% | 107,949,700 | |
| Aug 2026 | 15.92 | 28.32 | 15.84 | 25.49 | +62.67% | 122,617,700 | |
| Jul 2026 | 18.09 | 19.67 | 15.11 | 15.67 | -12.07% | 78,210,900 | |
| Jun 2026 | 16.46 | 19.97 | 15.43 | 17.82 | +6.58% | 62,653,600 | |
| May 2026 | 18.05 | 20.03 | 14.19 | 16.72 | -12.00% | 65,137,100 | |
| Apr 2026 | 18.89 | 22.16 | 17.40 | 19.00 | +6.26% | 36,716,900 | |
| Mar 2026 | 19.70 | 20.94 | 16.28 | 17.88 | -11.22% | 60,025,600 | |
| Feb 2026 | 22.86 | 23.99 | 17.15 | 20.14 | -13.04% | 45,998,100 | |
| 8 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Caris Life Sciences, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 12:53
- Piper Sandler Maintains Neutral on Caris Life Sciences, Raises Price Target to $25 (opens in a new tab) Benzinga · 10 Nov 2026 08:53
- BTSG vs. CAI: Which Stock Should Value Investors Buy Now? (opens in a new tab) Zacks · 09 Nov 2026 15:40
- Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer (opens in a new tab) 09 Nov 2026 13:30
- Caris Life Sciences Inc (CAI) Q3 2026 Earnings Call Highlights: Record Revenue, Sixth Straight ... (opens in a new tab) GuruFocus.com · 07 Nov 2026 13:04
- Citigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36 (opens in a new tab) Benzinga · 06 Nov 2026 17:25
- TD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $38 (opens in a new tab) Benzinga · 05 Nov 2026 16:27
- Caris Life (CAI) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 15:45
- 14% Below Fair Value? Caris Life Sciences (CAI) On Raised 2026 Guidance (opens in a new tab) Simply Wall St. · 05 Nov 2026 09:13
- BTIG Reiterates Buy on Caris Life Sciences, Maintains $38 Price Target (opens in a new tab) Benzinga · 05 Nov 2026 07:06
- Caris Life Sciences Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 01:14
- Caris Life Sciences (NASDAQ:CAI) Slides After Q3 Beat as Valuation Expectations Reset (opens in a new tab) ChartMill · 04 Nov 2026 23:15
- Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top Estimates (opens in a new tab) Zacks · 04 Nov 2026 21:50
- Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 21:44
- Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance (opens in a new tab) 04 Nov 2026 21:05
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 23.96 USD
- Market cap
- 6.9B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CAI and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.